Hormone therapy is an important treatment for transgender and gender non-conforming individuals who feel uncomfortable with their gender. Before starting, talk to our specialists to understand and agree to the treatment. You'll typically need a referral letter. Here are the main criteria: - Diagnosi...
Anti-androgen treatment to reduce the effect of endogenous male sex hormones An important principle— have realistic expectations Feminizing Hormones DO NOT Cause the voice to increase in pitch. Dramatically reduce facial hair growth in most people. There are some exceptions ...
However, many providers are uncomfortable prescribing transgender hormones due to fears over safety. The goal of this study was to determine if transgender hormone therapy with estrogen and spironolactone for male-to-female (MtF) patients or with testosterone for female-to-male (FtM) patients had ...
One further thing that made me think an exposure to artificial female hormones is the cause of my conditions was reading in the book “Brain Sex” about a pattern of behaviour commonly shown by teenage boys whose mothers were given treatment with a drug calleddiethylstilbestrol or DES in an at...
TransgenderEstradiolTestosteroneNeurotrophinGender identity disorderGender dysphoriaSerum levels of brain-derived neurotrophic factor (BDNF) are reduced in male-to-female transsexual persons (MtF) compared to male controls. It was hypothesized before that this might reflect either an involvement of BDNF in ...
The field of transgender care has rapidly expanded over the past few years, making it more imperative than ever that the implications of treatment be well understood. Although protocols have been developed regarding hormonal therapy for transgender patients, little evidence-based data has been ...
2014; received in revised form 17 November 2014; accepted 24 November 2014 KEYWORDS Transgender; Estradiol; Testosterone; Neurotrophin; Gender identity dis- order; Gender dysphoria Abstract Serum levels of brain-derived neurotrophic factor (BDNF) are reduced in male-to-female transsexual persons (MtF)...
Future studies in larger samples should account for such differences. In conclusion, we are able to show that although CSH brought about several changes in metabolite levels in transgender persons, the majority of a priori gender differences persisted throughout treatment. Even though the Scientific ...
Three uncontrolled prospective cohort studies, enrolling 247 transgender adults (180 male-to-female [MTF], 67 female-to-male [FTM]) initiating hormone therapy for the treatment of gender identity disorder (prior diagnostic term for gender dysphoria), were identified. The studies measured exposure to...
A 41-year-old male-to-female (MtF) transgender patient presented with a symptomatic tender lump in the left breast. There was no family history of breast cancer. She had been receiving estrogen therapy for 14 years to maintain her secondary sexual characteristics. Triple assessment revealed...